{
    "Trade/Device Name(s)": [
        "IMMULITE\u00ae 2000 CMV IgM"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K100433",
    "Predicate Device Reference 510(k) Number(s)": [
        "K933549"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LKQ",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "February 09, 2010",
    "Summary Letter Received Date": "February 16, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3175"
    ],
    "Regulation Name(s)": [
        "Cytomegalovirus serological reagents"
    ],
    "Analyte Class(es)": [
        "immunology",
        "virology",
        "serology"
    ],
    "Analyte(s)": [
        "IgM antibodies to cytomegalovirus (CMV)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IMMULITE\u00ae 2000 Systems analyzers"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme labeled chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "\u03bc-capture immunoassay",
        "Chemiluminescent immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE\u00ae 2000 CMV IgM qualitative immunoassay for detecting CMV IgM antibodies using IMMULITE\u00ae 2000 Systems.",
    "Indications for Use Summary": "Qualitative detection of IgM antibodies to CMV in human serum or plasma (EDTA or heparinized) as an aid in diagnosing current/recent CMV infection in individuals with clinical signs or suspicion of CMV; not for donor screening, neonatal screening, or point-of-care use.",
    "fda_folder": "Microbiology"
}